Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 4/2008

01-04-2008 | Concise Article

Disseminated cryptococcosis in HIV-uninfected patients

Authors: Y.-M. Chuang, Y.-C. Ho, H.-T. Chang, C.-J. Yu, P.-C. Yang, P.-R. Hsueh

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 4/2008

Login to get access

Abstract

Cryptococcus neoformans usually causes disease in patients with human immunodeficiency virus (HIV) infection. This descriptive study was based on a retrospective review of 33 HIV-uninfected patients with disseminated cryptococcosis from 1998 to 2005. An underlying condition associated with immunocompromise was documented in 30 patients (90.9%), including liver cirrhosis (36.4%), diabetes mellitus (33.3%) and autoimmune disease (27.3%). Disseminated cryptococcosis carried a high mortality rate in this series, reaching 63% overall, with a median survival of 21 days. All patients (12/12) with liver cirrhosis died within the first month after the diagnosis of cryptococcosis. Otherwise, high Acute Physiology and Chronic Health Evaluation II (APACHE II) score, female gender and smoking history were associated with worse one-month outcome.
Literature
1.
go back to reference Pappas PG, Perfect JR, Cloud GA, Larsen RA, Pankey GA, Lancaster DJ, Henderson H, Kauffman CA, Haas DW, Saccente M, Hamill RJ, Holloway MS, Warren RM, Dismukes WE (2001) Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis 33:690–699PubMedCrossRef Pappas PG, Perfect JR, Cloud GA, Larsen RA, Pankey GA, Lancaster DJ, Henderson H, Kauffman CA, Haas DW, Saccente M, Hamill RJ, Holloway MS, Warren RM, Dismukes WE (2001) Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis 33:690–699PubMedCrossRef
2.
go back to reference Rabkin JM, Oroloff SL, Corless CL, Benner KG, Flora KD, Rosen HR, Olyaei AJ (2000) Association of fungal infection and increased mortality in liver transplant recipients. Am J Surg 179:426–430PubMedCrossRef Rabkin JM, Oroloff SL, Corless CL, Benner KG, Flora KD, Rosen HR, Olyaei AJ (2000) Association of fungal infection and increased mortality in liver transplant recipients. Am J Surg 179:426–430PubMedCrossRef
3.
go back to reference Vilchez RA, Irish W, Lacomis J, Costello P, Fung J, Kusne S (2001) The clinical epidemiology of pulmonary cryptococcosis in non-AIDS patients at a tertiary care medical center. Medicine (Baltimore) 80:308–312CrossRef Vilchez RA, Irish W, Lacomis J, Costello P, Fung J, Kusne S (2001) The clinical epidemiology of pulmonary cryptococcosis in non-AIDS patients at a tertiary care medical center. Medicine (Baltimore) 80:308–312CrossRef
4.
go back to reference Jean SS, Fang CT, Shau WY, Chen YC, Chang SC, Hsueh PR, Hung CC, Luh KT (2002) Cryptococcaemia: clinical features and prognostic factors. QJM 95:511–518PubMedCrossRef Jean SS, Fang CT, Shau WY, Chen YC, Chang SC, Hsueh PR, Hung CC, Luh KT (2002) Cryptococcaemia: clinical features and prognostic factors. QJM 95:511–518PubMedCrossRef
5.
go back to reference Chayakulkeeree M, Perfect JR (2006) Cryptococcosis. Infect Dis Clin North Am 3:507–544CrossRef Chayakulkeeree M, Perfect JR (2006) Cryptococcosis. Infect Dis Clin North Am 3:507–544CrossRef
6.
go back to reference Kokturk N, Ekim N, Kervan F, Arman D, Memis L, Caglar K, Kalkanci A, Demircan S, Kurul C, Akyurek N (2005) Disseminated cryptococcosis in a human immunodeficiency virus-negative patient: a case report. Mycoses 48:270–274PubMedCrossRef Kokturk N, Ekim N, Kervan F, Arman D, Memis L, Caglar K, Kalkanci A, Demircan S, Kurul C, Akyurek N (2005) Disseminated cryptococcosis in a human immunodeficiency virus-negative patient: a case report. Mycoses 48:270–274PubMedCrossRef
7.
go back to reference Pasqualotto AC, Bittencourt Severo C, de Mattos Oliveira F, Severo LC (2004) Cryptococcemia. An analysis of 28 cases with emphasis on the clinical outcome and its etiologic agent. Rev Iberoam Micol 21:143–146PubMed Pasqualotto AC, Bittencourt Severo C, de Mattos Oliveira F, Severo LC (2004) Cryptococcemia. An analysis of 28 cases with emphasis on the clinical outcome and its etiologic agent. Rev Iberoam Micol 21:143–146PubMed
8.
go back to reference Wang CY, Wu HD, Hsueh PR (2005) Nosocomial transmission of cryptococcosis. N Engl J Med 352:1271–1272PubMedCrossRef Wang CY, Wu HD, Hsueh PR (2005) Nosocomial transmission of cryptococcosis. N Engl J Med 352:1271–1272PubMedCrossRef
9.
go back to reference Franca AV, Carneiro M, dal Sasso K, Souza Cda S, Martinelli A (2005) Cryptococcosis in cirrhotic patients. Mycoses 48:68–72PubMedCrossRef Franca AV, Carneiro M, dal Sasso K, Souza Cda S, Martinelli A (2005) Cryptococcosis in cirrhotic patients. Mycoses 48:68–72PubMedCrossRef
10.
go back to reference Mabee CL, Mabee SW, Kirkpatrick RB, Koletar SL (1995) Cirrhosis: a risk factor for cryptococcal peritonitis. Am J Gastroenterol 90:2042–2045PubMed Mabee CL, Mabee SW, Kirkpatrick RB, Koletar SL (1995) Cirrhosis: a risk factor for cryptococcal peritonitis. Am J Gastroenterol 90:2042–2045PubMed
11.
go back to reference Hsu CC, Leevy CM (1971) Inhibition of PHA-stimulated lymphocyte transformation by plasma from patients with advanced alcoholic cirrhosis. Clin Exp Immunol 8:749–760PubMed Hsu CC, Leevy CM (1971) Inhibition of PHA-stimulated lymphocyte transformation by plasma from patients with advanced alcoholic cirrhosis. Clin Exp Immunol 8:749–760PubMed
12.
go back to reference Nouri-Aria KT, Alexander GJ, Portmann BC, Hegarty JE, Eddleston AL, Williams R (1986) T and B cell function in alcoholic liver disease. J Hepatol 2:195–207PubMedCrossRef Nouri-Aria KT, Alexander GJ, Portmann BC, Hegarty JE, Eddleston AL, Williams R (1986) T and B cell function in alcoholic liver disease. J Hepatol 2:195–207PubMedCrossRef
13.
go back to reference Perfect JR, Durack DT, Gallis HA (1983) Cryptococcemia. Medicine (Baltimore) 62:98–109 Perfect JR, Durack DT, Gallis HA (1983) Cryptococcemia. Medicine (Baltimore) 62:98–109
Metadata
Title
Disseminated cryptococcosis in HIV-uninfected patients
Authors
Y.-M. Chuang
Y.-C. Ho
H.-T. Chang
C.-J. Yu
P.-C. Yang
P.-R. Hsueh
Publication date
01-04-2008
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 4/2008
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-007-0430-1

Other articles of this Issue 4/2008

European Journal of Clinical Microbiology & Infectious Diseases 4/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine